ArticleEuropean journal of clinical pharmacology2026
Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study.
Zi Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.